Green Thumb Industries Reports Second Quarter 2025 Results GlobeNewswire August 06, 2025 CHICAGO and VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for […]
Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization Company raises 2025 revenue guidance to a range of $122 million to $126 million GlobeNewswire August 06, 2025 SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind
Second quarter 2025 total revenue of $315 million Second quarter 2025 International revenue of $41 million Second quarter 2025 adjusted gross margin(1) of 49% Awarded license to operate in Turkey's nascent medical cannabis market Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today
Q2 2025 Revenue, Net Income, and Adjusted EBITDA Exceeded Guidance Simplification Continues with Sale of Graduate School USA, Redemption of All Preferred Equity, and Sale of Two Administrative Office Buildings American Public Education, Inc. (Nasdaq: APEI), a portfolio of education companies providing online and campus-based postsecondary education to over 105,000 students through three subsidiary institutions,
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Canaccord Genuity 45th Annual Growth Conference at 8:00 a.m. ET on Wednesday, August 13, 2025. Chief Executive Officer Kyle Gano and Vice-President of Investor Relations Todd Tushla will present at the conference. https://mma.prnewswire.com/media/678850/Neurocrine_Biosciences_Logo.jpg The live webcast can be accessed on Neurocrine Biosciences' website under Investors at
Xtant Medical Holdings, Inc.(NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced thatSean Browne, CEO andScott Neils, CFO will be attending the following upcoming conference: https://mma.prnewswire.com/media/2725938/XTNT_Logo.jpg Event: CG 45th AnnualGrowth ConferenceDate:August 12, 2025 at 3:30pm ETLocation:Boston, MAFormat: 1×1 Meetings & Presentation
PLANO, TX / ACCESS Newswire / August 6, 2025 / Intrusion Inc. (NASDAQ:INTZ) ("Intrusion" or the "Company"), a leader in cyberattack prevention solutions, will release its second quarter 2025 financial results on Tuesday, August 12, 2025, after market close. In conjunction with the report, Tony Scott, CEO, and Kimberly Pinson, CFO, will host a conference
Small business owners who want to exit their venture profitably can read the free guide released by IRAEmpire. It covers various aspects of selling a small business and gives valuable tips on how to expedite the process. MIAMI BEACH, FL / ACCESS Newswire / August 6, 2025 / IRAEmpire.com has released a new in-depth guide
IRVING, TX / ACCESS Newswire / August 6, 2025 / Envela Corporation ("Envela" or the "Company") today announced its financial results for its second quarter ended June 30, 2025. The Company reported quarterly revenue of $54.9 million and quarterly earnings per diluted share of $0.11. Management Commentary "Our team delivered strong second quarter results, driven
(NASDAQ:ELDN), Data from patients who remained on tegoprubart for a year showed overall mean 12-month eGFR of approximately 68 mL/min/1.73 m(2) post-transplant Preliminary iBox data, a key biomarker of kidney function and immunologic response, supports that tegoprubart may improve 5-year graft survival vs. current standard of care Tegoprubart continues to be well tolerated with no